william oh, md: the role of abiraterone plus prednisone in patients with diabetes
Published 8 years ago • 104 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:14
charles ryan, md: the role of abiraterone plus prednisone in patients with diabetes
-
1:26
william oh, md: the efficacy of abiraterone plus prednisone in an elderly patient population
-
0:39
william oh, md: the side effects of prednisone in combination with abiraterone
-
2:26
charles ryan, md: the efficacy of abiraterone plus prednisone in an elderly patient population
-
3:50
side effects of prednisone – dr.berg
-
4:14
aortic aneurysm repair explained by dr. william brinkman
-
52:45
current treatment options - stephen ansell, md
-
0:39
stereotactic body rt in patients with oligometastatic crpc undergoing 1l treatment with abiraterone
-
3:55
abiraterone plus prednisone in crpc: factors to consider
-
1:29
dr. william oh on the role of corticosteroids in treatment sequencing
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
2:00
william oh, md: differences between side effects of ar-targeted therapies
-
2:18
long-term exposure to low-dose prednisone with abiraterone acetate for mcrpc
-
1:35
charles ryan, md: the side effects for prednisone in combination with abiraterone
-
0:54
dr. ryan on the long term safety of abiraterone use
-
3:14
treatment with abiraterone acetate without steroids in mcrpc
-
1:34
william oh, md: comparison of chemotherapy to a secondary hormone at the time of progression
-
10:00
results from acis trial of apalutamide abiraterone/prednisone in patients with chemo-naive mcrpc
-
1:41
dr. oh on abiraterone versus docetaxel in prostate cancer
-
7:09
overall survival with abiraterone acetate plus prednisone in peace-1
-
1:15
dr. oh on the hormone-sensitive setting in prostate cancer
-
0:54
convincing long-term survival with abiraterone in mcrpc